Vitrolife AB (publ) (FRA:VTFN)

Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of EUR 1.71 billion. The enterprise value is 1.80 billion.

Market Cap	1.71B
Enterprise Value	1.80B

Important Dates

The last earnings date was Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	135.42M
Shares Outstanding	n/a
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	75.04M

Valuation Ratios

The trailing PE ratio is 41.91 and the forward PE ratio is 32.47.

PE Ratio	41.91
Forward PE	32.47
PS Ratio	5.39
PB Ratio	1.44
P/TBV Ratio	n/a
P/FCF Ratio	35.38
P/OCF Ratio	27.52
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.99, with an EV/FCF ratio of 37.36.

EV / Earnings	44.26
EV / Sales	5.70
EV / EBITDA	17.99
EV / EBIT	29.04
EV / FCF	37.36

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.15.

Current Ratio	3.41
Quick Ratio	2.61
Debt / Equity	0.15
Debt / EBITDA	1.78
Debt / FCF	3.70
Interest Coverage	7.09

Financial Efficiency

Return on equity (ROE) is 3.45% and return on invested capital (ROIC) is 2.85%.

Return on Equity (ROE)	3.45%
Return on Assets (ROA)	2.58%
Return on Invested Capital (ROIC)	2.85%
Return on Capital Employed (ROCE)	4.29%
Revenue Per Employee	276,437
Profits Per Employee	35,521
Employee Count	1,169
Asset Turnover	0.21
Inventory Turnover	3.63

Taxes

In the past 12 months, Vitrolife AB has paid 13.97 million in taxes.

Income Tax	13.97M
Effective Tax Rate	25.53%

Stock Price Statistics

The stock price has decreased by -36.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.38%
50-Day Moving Average	12.93
200-Day Moving Average	16.12
Relative Strength Index (RSI)	46.12
Average Volume (20 Days)	75

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of EUR 317.07 million and earned 40.74 million in profits. Earnings per share was 0.30.

Revenue	317.07M
Gross Profit	186.61M
Operating Income	62.23M
Pretax Income	54.71M
Net Income	40.74M
EBITDA	96.08M
EBIT	62.23M
Earnings Per Share (EPS)	0.30

Balance Sheet

The company has 82.47 million in cash and 178.46 million in debt, giving a net cash position of -95.99 million.

Cash & Cash Equivalents	82.47M
Total Debt	178.46M
Net Cash	-95.99M
Net Cash Per Share	n/a
Equity (Book Value)	1.19B
Book Value Per Share	8.78
Working Capital	138.08M

Cash Flow

In the last 12 months, operating cash flow was 62.05 million and capital expenditures -13.79 million, giving a free cash flow of 48.26 million.

Operating Cash Flow	62.05M
Capital Expenditures	-13.79M
Free Cash Flow	48.26M
FCF Per Share	n/a

Margins

Gross margin is 58.85%, with operating and profit margins of 19.63% and 12.85%.

Gross Margin	58.85%
Operating Margin	19.63%
Pretax Margin	17.26%
Profit Margin	12.85%
EBITDA Margin	30.30%
EBIT Margin	19.63%
FCF Margin	15.22%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.80%.

Dividend Per Share	0.10
Dividend Yield	0.80%
Dividend Growth (YoY)	17.20%
Years of Dividend Growth	1
Payout Ratio	32.75%
Buyback Yield	-0.10%
Shareholder Yield	0.71%
Earnings Yield	2.39%
FCF Yield	2.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 4.9 and a Piotroski F-Score of 8.

Altman Z-Score	4.9
Piotroski F-Score	8